Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

Q2 2019 13F Holders as of 6/30/2019

Type / Class
Equity / COMMON STOCK
Shares outstanding
112M
Number of holders
148
Total 13F shares, excl. options
45.1M
Shares change
-234K
Total reported value, excl. options
$374M
Value change
-$7.41M
Put/Call ratio
0.56
Number of buys
70
Number of sells
-62
Price
$8.30

Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2019

192 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q2 2019.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 45.1M shares of 112M outstanding shares and own 40.14% of the company stock.
Largest 10 shareholders include STATE STREET CORP (6.93M shares), ArrowMark Colorado Holdings LLC (6.85M shares), BlackRock Inc. (4.4M shares), VANGUARD GROUP INC (3.7M shares), FMR LLC (3.06M shares), Park West Asset Management LLC (1.75M shares), Fiera Capital Corp (1.34M shares), NORTHERN TRUST CORP (769K shares), Sio Capital Management, LLC (755K shares), and GEODE CAPITAL MANAGEMENT, LLC (740K shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.